MedTrace Logo

EnSite™ HD Grid Catheter AF/AT Mapping Study

NCT02656537 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2019-02-01

No results posted yet for this study

Summary

In this clinical investigation, the safety, feasibility and performance of the novel EnSite™ HD Grid Catheter mapping system for advanced high-density three-dimensional mapping will be studied in patients undergoing catheter ablation procedures for the treatment of non-paroxysmal atrial fibrillation (AF) or left atrial tachycardia (AT).

Conditions

  • Non-paroxysmal Atrial Fibrillation
  • Left Atrial Tachycardia

Interventions

DEVICE

EnSite™ HD Grid Catheter mapping system

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Carlo Pappone, MD, PhD · San Donato Hospital, Italy

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2018-02-28
Completion
2018-08-31

Countries

  • Australia
  • France
  • Germany
  • Hong Kong
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02656537 on ClinicalTrials.gov